Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 94 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7976851

    Non-toxic biofilm inhibitor

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  2. US 7977359

    5-lipdxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  3. US 7977488

    1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  4. US 7968545

    Compositions useful as inhibitors of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  5. US 7968080

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  6. US 7968716

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  7. US 7964748

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  8. US 7964624

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  9. US 7960384

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  10. US 7960415

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  11. US 7960383

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  12. US 7956220

    MAO-B inhibitors useful for treating obesity

    Jenrin Discovery, LLC · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted

  13. US 7951831

    Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

    The Regents of the University of California · Granted May 31, 2011 · Expires May 26, 2031

    granted

  14. US 7951548

    IL-13 production inhibitor

    Takeda Pharmaceutical Company Limited · Granted May 31, 2011 · Expires May 26, 2031

    granted

  15. US 7951809

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted

  16. US 7951820

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted

  17. US 7951770

    Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process

    Northwestern University · Granted May 31, 2011 · Expires May 26, 2031

    granted

  18. US 7943626

    Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted

  19. US 7943159

    Female sex pheromone of the dogwood borer (DWB), Synanthedon scitula, and attraction inhibitor (antagonist)

    The United States of America, as represented by the Secretary of Agriculture · Granted May 17, 2011 · Expires May 12, 2031

    granted

  20. US 7943593

    Compositions comprising inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted May 17, 2011 · Expires May 12, 2031

    granted

  21. US 7943659

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted

  22. US 7935693

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  23. US 7928129

    Nanomolar β-lactamase inhibitors

    Northwestern University · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  24. US 7919523

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.